Repetitive high-dose ifosfamide, thiotepa and paclitaxel (ITP) with peripheral blood progenitor cell support; A novel outpatient regimen for metastatic and locally advanced breast cancer.

被引：0
|
作者：
Prince, HM [1 ]
Millward, MJ [1 ]
Rischin, DR [1 ]
Blakey, D [1 ]
Wolf, M [1 ]
Januscewicz, H [1 ]
Toner, G [1 ]
Richardson, G [1 ]
Sharkey, P [1 ]
Dale, B [1 ]
机构：
[1] PETER MACCALLUM CANC INST,BLOOD & MARROW TRANSPLANT SERV,MELBOURNE,VIC 3000,AUSTRALIA
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4575 / 4575
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support
    vanWarmerdam, LJC
    Rodenhuis, S
    vanderWall, E
    Maes, RAA
    Beijnen, JH
    BRITISH JOURNAL OF CANCER, 1996, 73 (08) : 979 - 984
  • [42] High-dose chemotherapy with stem cell support in breast cancer: Does cyclophosphamide alter high-dose thiotepa pharmacokinetics?
    Dobrovolskaja, A
    Nitz, U
    Frick, M
    Bender, HG
    Burk, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S37 - S37
  • [43] Multiple-cycle high-dose paclitaxel, doxorubicin, and cyclophosphamide with peripheral blood progenitor cells and granulocyte colony-stimulating factor support in patients with metastatic breast cancer
    Rahman, Z
    Frye, D
    Champlin, R
    Rondón, G
    Hortobagyi, G
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 30 - 30
  • [44] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in metastatic breast cancer.: Updated results of a single center
    Okan, K.
    Komurcu, S.
    Arpaci, F.
    Ozet, A.
    Beyzadeoglu, M.
    Ulutin, C.
    Ataergin, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 132 - 132
  • [45] Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer
    Klein, JL
    Rey, PM
    Dansey, RD
    Karanes, C
    Du, W
    Abella, E
    Cassells, L
    Hamm, C
    Peters, WP
    Baynes, RD
    BONE MARROW TRANSPLANTATION, 2000, 25 (10) : 1047 - 1052
  • [46] High-dose busulfan and cyclophosphamide followed by autologous bone marrow transplantation and/or peripheral blood progenitor cell rescue for metastatic breast cancer
    Kalaycioglu, ME
    Lichtin, AE
    Andresen, SW
    Tuason, L
    Bolwell, BJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06): : 491 - 494
  • [47] Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer
    JL Klein
    PMaroto Rey
    RD Dansey
    C Karanes
    W Du
    E Abella
    L Cassells
    C Hamm
    WP Peters
    RD Baynes
    Bone Marrow Transplantation, 2000, 25 : 1047 - 1052
  • [48] Two cycles of high-dose chemotherapy with peripheral blood progenitor cell rescue in patients with metastatic breast cancer responsive to induction chemotherapy
    De Rosa, L
    Anghel, G
    Lalle, M
    Pescador, L
    Pandolfi, A
    Majolino, I
    BONE MARROW TRANSPLANTATION, 2003, 31 : S194 - S194
  • [49] A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer
    Glück, S
    Germond, C
    Lopez, P
    Cano, P
    Dorreen, M
    Koski, T
    Arnold, A
    Dulude, H
    Gallant, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (07) : 1008 - 1014
  • [50] High-dose chemotherapy (HDC) and autologous peripheral blood stem cell support (PBSC) in patients with metastatic breast cancer (MBC)
    Huober, J
    Wallwiener, D
    Fersis, N
    Bastert, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 415 - 415
12345